Skip to main content
m-mainSlide1
NTL connects healthcare and technology with people to create a healthy world
NTL combines healthcare and IT to provide an integrative solution for Cervical cancer diagnosis.
m-mainSlide2
NTL increases diagnostic accuracy
by adding AI (Artificial Intelligence) to big data
NTL, which has led the world's Cervicography for the past 27 years, is leading the new artificial intelligence Cervical cancer diagnosis market.
m-mainSlide3
All women in the world are mothers
and daughters of someone precious
NTL creates a healthy tomorrow for a world where all women can be free from cervical cancer, regardless of borders and regions.
previous arrow
next arrow
Cervicography

TeleCervicography

Read in detail

AI Diagnostic System

CerviCARE® AI

Read in detail

References

Clinical Data

Read in detail

Global No.1

NTL is specializing in female cancer
with the world’s most advanced technology in the field of Cervicography,
A medical device for early diagnosis of uterine cervical cancer.

6,000,000

Cervicography Service

Ref) Internal Market Research

27

Business Experience

Ref) Internal Market Research

80

Market share in Korea

Ref) Internal Market Research

500000

Every year

Ref) Internal Market Research

Here we introduce
the main businesses of NTL

Play Video
  • CerviCARE AI enables to see get the results in a few seconds at the Point-of-Care.
  • If an abnormality is found, it can be consulted by requesting reading to 45 professors specializing in gynecologic oncology at 32 university hospitals.
Play Video
  • NTL is specializing in female cancer with the world’s most advanced technology in the field of Cervicography,
    A medical device for early diagnosis of uterine cervical cancer.